Oberland Capital Asset Manager Profile - aVenture Research
Oberland Capital is a private investment firm focused on providing financing solutions within the healthcare industry. The firm specializes in flexible investment structures tailored to support the development and commercialization of innovative healthcare products. Oberland Capital typically engages in various investment rounds, including Series A, post-IPO debt, and post-IPO equity, with a significant presence in the United States healthcare market.
Notable portfolio companies include ImmunityBio, Mirum Pharmaceuticals, NorthStar Medical Radioisotopes, Primmune Therapeutics, and Zealand Pharma. Oberland Capital's key partners bring extensive experience and industry connections, enhancing their ability to offer unique value-add services such as strategic guidance and operational support to their portfolio companies. This approach aims to create value for partners and transform patient care globally.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.